A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Public ClinicalTrials.gov record NCT02584855. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter Study With a 36-Week Open-Label Period Followed by a Randomized Double-Blind Withdrawal Period From Week 36 to Week 104 to Evaluate the Long-Term Efficacy and Safety of Ixekizumab (LY2439821) 80 mg Every 2 Weeks in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Active Psoriatic Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate the safety and long-term efficacy of ixekizumab compared to placebo in participants with active psoriatic arthritis.
Study identification
- NCT ID
- NCT02584855
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 394 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2015 (Actual)
- Primary completion
- Oct 30, 2018 (Actual)
- Completion
- Oct 30, 2018 (Actual)
- Last update posted
- Nov 15, 2019
2015 – 2018
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis & Rheumatology Research | Glendale | Arizona | 85306 | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Mesa | Arizona | 85202 | — |
| Arizona Arthritis Research, PLC | Phoenix | Arizona | 85032 | — |
| University of California, Davis - Health Systems | Sacramento | California | 95817 | — |
| East Bay Rheumatology Medical Group | San Leandro | California | 94578 | — |
| Arthritis & Osteoporosis Treatment Center, PA | Orange Park | Florida | 32073 | — |
| Florida Medical Clinic PA | Zephyrhills | Florida | 33542 | — |
| Physicians Clinic of Iowa | Cedar Rapids | Iowa | 54203 | — |
| Heartland Research Associates | Wichita | Kansas | 67207 | — |
| Klein and Associates MD, PA | Cumberland | Maryland | 21502 | — |
| Klein and Associates MD, PA | Hagerstown | Maryland | 21740 | — |
| University of Massachusetts Medical Center | Worcester | Massachusetts | 01605 | — |
| Glacier View Research Institute | Kalispell | Montana | 59901 | — |
| Arthritis, Rheumatic & Back Disease Associates | Voorhees Township | New Jersey | 08043 | — |
| Weill Cornell Physicians at Brooklyn Heights | Brooklyn | New York | 11201 | — |
| Robert A. Harrell, III, MD | Durham | North Carolina | 27704 | — |
| Pennsylvania Regional Center for Arthritis & Osteoarthritis | Wyomissing | Pennsylvania | 19610 | — |
| Pioneer Research Solutions | Cypress | Texas | 77429 | — |
| Arthritis Care & Diagnostic Center P.A. | Dallas | Texas | 75231 | — |
| Kadlec Clinic Rheumatology | Kennewick | Washington | 99336 | — |
| Seattle Rheumatology Associates, P.L.L.C. | Seattle | Washington | 98122 | — |
| Arthritis Northwest Rheumatology | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02584855, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2019 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02584855 live on ClinicalTrials.gov.